Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat in Advanced Prostate Cancer
NCT00330161Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2006
- Primary completion
- Sep 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in prostate cancer (PCa), sponsored by National Cancer Institute. Started Mar 2006; status: completed.
02
Drugs
vorinostat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00330161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330161.